Dimensional Fund Advisors
ACET icon

Dimensional Fund Advisors’s Adicet Bio ACET Stock Holding History

Dimensional Fund Advisors’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.4K Buy
+10,778
New +$80.7K ﹤0.01% 3140
2025
Q4 		– Sell
-3,310
Closed -$42.9K – 3241
2025
Q3 		$42.9K Sell
3,310
-269
-8% -$3.17K ﹤0.01% 3247
2025
Q2 		$34.9K Sell
3,579
-5,659
-61% -$59.7K ﹤0.01% 3253
2025
Q1 		$112K Hold
9,238
– – ﹤0.01% 3193
2024
Q4 		$142K Hold
9,238
– – ﹤0.01% 3198
2024
Q3 		$213K Hold
9,238
– – ﹤0.01% 3162
2024
Q2 		$179K Sell
9,238
-2,595
-22% -$69.5K ﹤0.01% 3183
2024
Q1 		$445K Buy
11,833
+2,245
+23% +$92.9K ﹤0.01% 3063
2023
Q4 		$290K Sell
9,588
-469
-5% -$10.2K ﹤0.01% 3141
2023
Q3 		$221K Sell
10,057
-10,500
-51% -$371K ﹤0.01% 3202
2023
Q2 		$799K Sell
20,557
-14,341
-41% -$1.27M ﹤0.01% 2965
2023
Q1 		$3.22M Sell
34,898
-6,804
-16% -$854K ﹤0.01% 2612
2022
Q4 		$5.96K Buy
41,702
+17,332
+71% +$4.33M ﹤0.01% 2393
2022
Q3 		$5.54M Buy
24,370
+12,888
+112% +$3.27M ﹤0.01% 2390
2022
Q2 		$2.68M Buy
11,482
+6,569
+134% +$1.44M ﹤0.01% 2650
2022
Q1 		$1.57M Buy
4,913
+3,239
+193% +$745K ﹤0.01% 2883
2021
Q4 		$468K Buy
1,674
+108
+7% +$18.5K ﹤0.01% 3180
2021
Q3 		$197K Sell
1,566
-621
-28% -$77K ﹤0.01% 3351
2021
Q2 		$360K Buy
+2,187
New +$445K ﹤0.01% 3229

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dimensional Fund Advisors's ACET Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in Adicet Bio (ACET) in Q1 2026: 10,778 shares worth $73.4K. The stake represents ﹤0.01% of the portfolio and ranks #3140 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in ACET as recently as Q3 2025.

Dimensional Fund Advisors first reported a position in ACET in Q2 2021 and has held it in 19 quarters since. The position peaked at $5.54M in Q3 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Dimensional Fund Advisors held 10,778 shares of Adicet Bio worth $73.4K as of Q1 2026.
  • Adicet Bio was a new Dimensional Fund Advisors position in Q1 2026.
  • Adicet Bio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3140 holding.
  • Dimensional Fund Advisors first reported a position in Adicet Bio in Q2 2021 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Adicet Bio position peaked at $5.54M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.